Clinical History: An 84-year-old male patient, known case of HTN and dyslipidemia, complaining of dysphasia for three months. Anorexia and vomiting. Diagnosed as esophageal adenocarcinoma outside for evaluation.
Clinical History: An 84-year-old male patient, known case of HTN and dyslipidemia, complaining of dysphasia for three months. Anorexia and vomiting. Diagnosed as esophageal adenocarcinoma outside for evaluation.
A CT scan of chest with IV contrast and CT of the abdomen and pelvis done with IV and oral negative contrast.
Findings:
Large stomach mass found with extension to the gastroesophageal junction/lower esophagus with evidence of peritoneal carcinomatosis. No metastatic disease seen in the liver or lungs.
Pathology:
Gastric biopsy : Mucinous adenocarcinoma grade2/3
Peritoneal biopsy: Metastatic mucinous adenocarcinoma
Gastric cancer, commonly referred to as stomach cancer, can develop in any part of the stomach and may spread throughout the stomach and to other organs; particularly the esophagus, lungs, lymph nodes, and the liver. Stomach cancer causes about 800,000 deaths worldwide per year.
Signs and symptoms:
Stomach cancer is often asymptomatic or causes only nonspecific symptoms in its early stages. By the time symptoms occur, the cancer has often reached an advanced stage, one of the main reasons for its poor prognosis.
Stomach cancer can cause the following signs and symptoms:
Stage 1 (Early) - Indigestion or a burning sensation (heartburn), loss of appetite, especially for meat, abdominal discomfort or irritation
Stage 2 (Middle) - Weakness and fatigue, bloating of the stomach, usually after meals
Stage 3 (Late) - Abdominal pain in the upper abdomen; nausea and occasional vomiting; diarrhea or constipation; weight loss; bleeding (vomiting blood or having blood in the stool) which will appear as black and can lead to anemia; dysphagia (This feature suggests a tumor in the cardia or extension of the gastric tumor in to the esophagus.)
Diagnosis:
To find the cause of symptoms, the doctor asks about the patient's medical history, does a physical exam, and may order laboratory studies. The patient may also have one or all of the following exams:
Gastroscopic exam is the diagnostic method of choice. This involves insertion of a fiber optic camera into the stomach to visualize it.
Upper GI series (may be called barium roentgenogram)
Computed tomography or CT scanning of the abdomen may reveal gastric cancer, but is more useful to determine invasion into adjacent tissues, or the presence of spread to local lymph nodes.
Discussion:
Mucinous gastric carcinoma has been termed mucoid, colloid, or gelatinous carcinoma . It is a rare subtype of gastric carcinoma that represents approximately 3 percent to 5 percent of all gastric epithelial cancers. Previously, however, there was no criterion for classifying the mucin-producing form of this tumor, and no distinction between those with intracellular mucin and those with extracellular mucin was made. The World Health Organization classifies gastric carcinoma into four types-(a) papillary, (b) tubular, (c) mucinous, and (d) signet ring cell - and defines mucinous gastric carcinoma as “an adenocarcinoma in which a substantial amount of extracellular mucin (more than 50 percent of the tumor) is retained within the tumor.
Both primary and metastatic gastrointestinal neoplasms may calcify. Mucinous adenocarcinomas of the stomach and colon can demonstrate a sand-like calcific pattern. Larger more discrete focal areas of calcification occasionally can be seen within leiomyomas of the esophagus or stomach, similar in appearance to the more common leiomyomas of the uterus. Clusters of phlebolithic calcifications may indicate a hemangiomatous lesion within the GI tract. Pancreatic cystadenomas or cystadenocarcinomas can have a characteristic sunburst calcified pattern. Neoplastic calcification within the liver is most commonly from metastatic disease and should prompt a search for a similar calcific pattern elsewhere within the abdomen indicating the primary tumor.
The type of degenerative calcification exemplified by this case should not be confused with psammomatous calcification which is characteristic for either the primary or secondary papillary serous cystadenocarcinomas of the ovary. Psammomatous calcifications are 5 to 100 microns in diameter and present radiographically as hazy cloud-like areas of calcification rather than the more focal sand-like calcification demonstrated in this case.
The differential diagnosis of organ calcifications in the left upper quadrant relies on recognition of the organ involved and distinguishing a sunburst, phlebolithic, or coarse calcified pattern.
Sushila Ladumor, MD, FRCR, Consultant Radiologist with Multi-modality Imaging experience, working in Medical Imaging Department, King Abdulaziz Medical City, Riyadh, Saudi Arabia.
References:
Diagnosis of Gastric Cancer with MDCT Using the Water-Filling Method and Multiplanar Reconstruction: CT-Histologic CorrelationAm. J. Roentgenol. November 1, 2005 185:1152-1158
Scirrhous Gastric Carcinoma: Endoscopy versus Upper Gastrointestinal RadiographyRadiology May 1, 2004 231:421-426
http://rad.usuhs.edu/medpix/new_topic.html?mode=single&recnum=1592&quiz=#pic
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.